SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-24-239717
Filing Date
2024-10-18
Accepted
2024-10-18 17:29:27
Documents
3
Period of Report
2024-11-12

Document Format Files

Seq Description Document Type Size
1 PRE 14A d773865dpre14a.htm PRE 14A 435146
2 GRAPHIC g773865im01a.jpg GRAPHIC 968
3 GRAPHIC g773865im01b.jpg GRAPHIC 907
  Complete submission text file 0001193125-24-239717.txt   439124
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

IRS No.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41390 | Film No.: 241381541
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)